![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
ARTICOLO ORIGINALE
La Rivista Italiana della Medicina di Laboratorio 2022 Giugno;18(2):85-90
DOI: 10.23736/S1825-859X.22.00143-8
Copyright © 2022 EDIZIONI MINERVA MEDICA
lingua: Inglese
The impact of COVID-19 on some aspects of laboratory activities
Recai ACI 1 ✉, Adem KESKIN 2
1 Department of Biochemistry, Samsun Training and Research Hospital, Health Sciences University, Samsun, Turkey; 2 Department of Medicine Biochemistry, Institute of Health Sciences, Aydin Adnan Menderes University, Aydin, Turkey
BACKGROUND: The COVID-19 outbreak has affected the activities of many fields. This study aimed to evaluate the impact of the COVID-19 outbreak on laboratory activity.
METHODS: The data of the study were obtained from a single-center homogeneous group in the biochemistry laboratory of Samsun Training and Research Hospital. These data were divided into two patient groups: Group A (Pre-COVID-19 outbreak period patients) and Group B (COVID-19 outbreak period patients). Erythrocyte sedimentation rate (ESR), hormones, coagulation, glycosylated hemoglobin, biochemistry, complete blood count (CBC), blood gas, urine sample types, and pre-analytical errors were included. The data of the two groups were compared with the chi-square test.
RESULTS: The number of samples requested per patient was 0.62 in Group A and 0.67 in Group B. The reduction rate detected in biochemistry (P<0.001), blood gas (P<0.001) and CBC (P=0.007) sample types was lower than the reduction rate detected in the number of patients in Group B. On the other hand, the reduction rate detected in ESR (P<0.001), coagulation (P=0.045), glycosylated hemoglobin (P<0.001), and urine (P<0.001) sample types was higher than the reduction rate detected in the number of patients in Group B. The pre-analytical error rate in Group B (0.46%) was higher than in Group A (0.29%) (P<0.001). The rate of hemolyzed samples was higher, and the rate of the incorrect request was lower in Group B.
CONCLUSIONS: Laboratory test requests per patient and pre-analytical error rates increased significantly during the COVID-19 outbreak.
KEY WORDS: Pandemics; COVID-19; Laboratories. Pre-analytical error